tradingkey.logo

Bone Biologics Corp

BBLG
1.630USD
0.0000.00%
交易中 美東報價延遲15分鐘
2.93M總市值
虧損本益比TTM

Bone Biologics Corp

1.630
0.0000.00%

關於 Bone Biologics Corp 公司

Bone Biologics Corporation is a clinical-stage developer of orthobiologic products for spine fusion markets. The Company is focused on bone regeneration in lumbar spinal fusion using neural epidermal growth factor-like 1 protein (NELL-1) in combination with demineralized bone matrix (DBM), a demineralized bone matrix from the Musculoskeletal Transplant Foundation (MTF) Biologics. The combination NELL-1/DBM medical device is an osteopromotive recombinant protein that provides target specific control over bone regeneration. NELL-1 in combination with DBM. NELL-1, a proprietary skeletal-specific growth factor that is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.

Bone Biologics Corp簡介

公司代碼BBLG
公司名稱Bone Biologics Corp
上市日期Nov 27, 2015
CEOFrelick (Jeffrey)
員工數量2
證券類型Ordinary Share
年結日Nov 27
公司地址2 Burlington Woods Dr Ste 100
城市BURLINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編01803-4551
電話17815524452
網址https://www.bonebiologics.com/
公司代碼BBLG
上市日期Nov 27, 2015
CEOFrelick (Jeffrey)

Bone Biologics Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+3.00%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--
Mr. Jody Cain
Mr. Jody Cain
Investor Relation
Investor Relation
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Jeffrey Frelick
Mr. Jeffrey Frelick
President, Chief Executive Officer
President, Chief Executive Officer
359.00
+3.00%
Ms. Deina H. Walsh, CPA
Ms. Deina H. Walsh, CPA
Chief Financial Officer
Chief Financial Officer
313.00
--
Mr. Bruce Stroever
Mr. Bruce Stroever
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Dr. Siddhesh Rajendra (Sid) Angle, Ph.D.
Independent Director
Independent Director
--
--
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Independent Director
Independent Director
--
--
Mr. Phillip T. Meikle
Mr. Phillip T. Meikle
Independent Director
Independent Director
--
--

收入明細

由於公司未披露,未能獲取相關數據
由於公司未披露,未能獲取相關數據
業務
地區
由於公司未披露,未能獲取相關數據

股東統計

更新時間: 17 小時前
更新時間: 17 小時前
持股股東
股東類型
持股股東
持股股東
佔比
DRW Securities, LLC
0.61%
Geode Capital Management, L.L.C.
0.35%
UBS Financial Services, Inc.
0.11%
Tower Research Capital LLC
0.08%
Frelick (Jeffrey)
0.02%
其他
98.83%
持股股東
持股股東
佔比
DRW Securities, LLC
0.61%
Geode Capital Management, L.L.C.
0.35%
UBS Financial Services, Inc.
0.11%
Tower Research Capital LLC
0.08%
Frelick (Jeffrey)
0.02%
其他
98.83%
股東類型
持股股東
佔比
Investment Advisor
0.73%
Investment Advisor/Hedge Fund
0.35%
Hedge Fund
0.08%
Individual Investor
0.04%
Research Firm
0.03%
其他
98.77%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
15
13.28K
0.99%
--
2025Q3
23
14.93K
1.62%
+12.83K
2025Q2
23
2.10K
1.96%
-3.89K
2025Q1
23
5.99K
6.22%
-27.92K
2024Q4
25
11.69K
8.76%
-6.90K
2024Q3
24
17.54K
8.58%
+4.95K
2024Q2
23
11.22K
11.00%
+2.60K
2024Q1
23
8.62K
9.21%
-4.88K
2023Q4
22
1.85K
15.09%
-9.81K
2023Q3
21
11.67K
14.02%
-1.55K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
DRW Securities, LLC
11.03K
0.61%
+11.03K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
--
0%
-4.03K
-100.00%
Jun 30, 2025
UBS Financial Services, Inc.
66.00
0%
-47.00
-41.59%
Sep 30, 2025
Tower Research Capital LLC
1.46K
0.08%
+1.26K
+632.00%
Sep 30, 2025
Frelick (Jeffrey)
359.00
0.02%
+3.00
+0.84%
Apr 11, 2025
Walsh (Deina H)
313.00
0.02%
--
--
Apr 11, 2025
SBI Securities Co., Ltd.
230.00
0.01%
+230.00
--
Sep 30, 2025
Citi Investment Research (US)
206.00
0.01%
+206.00
--
Sep 30, 2025
Clear Street Group Inc
138.00
0.01%
+138.00
--
Sep 30, 2025
Clear Street LLC
138.00
0.01%
+138.00
--
Jun 30, 2025
查看更多

持股ETF

機構名稱
佔比
暫無數據

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Jun 06, 2025
Merger
6→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Jun 06, 2023
Merger
30→1
公告日期
除權除息日
類型
比率
Jun 06, 2025
Merger
6→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Dec 18, 2023
Merger
8→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
Jun 06, 2023
Merger
30→1
KeyAI